Pancreatitis of biliary origin, optimal timing of cholecystectomy (PONCHO trial): study protocol for a randomized controlled trial
Stefan A Bouwense,Marc G Besselink,Sandra van Brunschot,Olaf J Bakker,Hjalmar C van Santvoort,Nicolien J Schepers,Marja A Boermeester,Thomas L Bollen,Koop Bosscha,Menno A Brink,Marco J Bruno,Esther C Consten,Cornelis H Dejong,Peter van Duijvendijk,Casper H van Eijck,Jos J Gerritsen,Harry van Goor,Joos Heisterkamp,Ignace H de Hingh,Philip M Kruyt,I Quintus Molenaar,Vincent B Nieuwenhuijs,Camiel Rosman,Alexander F Schaapherder,Joris J Scheepers,Marcel BW Spanier,Robin Timmer,Bas L Weusten,Ben J Witteman,Bert van Ramshorst,Hein G Gooszen,Djamila Boerma,for the Dutch Pancreatitis Study Group,
DOI: https://doi.org/10.1186/1745-6215-13-225
IF: 2.728
2012-11-26
Trials
Abstract:Abstract Background After an initial attack of biliary pancreatitis, cholecystectomy minimizes the risk of recurrent biliary pancreatitis and other gallstone-related complications. Guidelines advocate performing cholecystectomy within 2 to 4 weeks after discharge for mild biliary pancreatitis. During this waiting period, the patient is at risk of recurrent biliary events. In current clinical practice, surgeons usually postpone cholecystectomy for 6 weeks due to a perceived risk of a more difficult dissection in the early days following pancreatitis and for logistical reasons. We hypothesize that early laparoscopic cholecystectomy minimizes the risk of recurrent biliary pancreatitis or other complications of gallstone disease in patients with mild biliary pancreatitis without increasing the difficulty of dissection and the surgical complication rate compared with interval laparoscopic cholecystectomy. Methods/Design PONCHO is a randomized controlled, parallel-group, assessor-blinded, superiority multicenter trial. Patients are randomly allocated to undergo early laparoscopic cholecystectomy, within 72 hours after randomization, or interval laparoscopic cholecystectomy, 25 to 30 days after randomization. During a 30-month period, 266 patients will be enrolled from 18 hospitals of the Dutch Pancreatitis Study Group. The primary endpoint is a composite endpoint of mortality and acute re-admissions for biliary events (that is, recurrent biliary pancreatitis, acute cholecystitis, symptomatic/obstructive choledocholithiasis requiring endoscopic retrograde cholangiopancreaticography including cholangitis (with/without endoscopic sphincterotomy), and uncomplicated biliary colics) occurring within 6 months following randomization. Secondary endpoints include the individual endpoints of the composite endpoint, surgical and other complications, technical difficulty of cholecystectomy and costs. Discussion The PONCHO trial is designed to show that early laparoscopic cholecystectomy (within 72 hours) reduces the combined endpoint of mortality and re-admissions for biliary events as compared with interval laparoscopic cholecystectomy (between 25 and 30 days) after recovery of a first episode of mild biliary pancreatitis. Trial registration Current Controlled Trials: ISRCTN72764151
medicine, research & experimental